Coming to loans, personal loans increased by 13% in FY25 and FY26 which is softer versus the earlier years. Also, the recent resurgence in ...

Many Democrats, some Republicans, and industry trade groups are unhappy about a provision in the long-stalled bill that would let Trump imp...

The Federal Reserve maintained its benchmark interest rate, resisting President Donald Trump's calls for a reduction. Three officials disse...

Indian equities ended lower on Tuesday as Sensex and Nifty erased early gains after a sharp rally. Analysts cited cautious sentiment ahead ...

Indian equity benchmarks ended marginally lower after surrendering early gains as IT stocks outperformed but weakness in FMCG, power and de...

Indian stock markets closed lower on Tuesday after erasing early gains. Sensex and Nifty experienced a slight decline, while broader market...

US tariff move draws mixed response from India's textile industry, with some fearing export disruption while others see a competitive oppor...

Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...

The Trump administration imposed significant tariffs on many nations recently. These tariffs target countries with alleged forced labor imp...

India's gem and jewellery exporters welcomed the US decision to retain the additional tariff on Indian shipments at 10%, giving them a tari...

The United States has reduced tariffs on most Indian exports to ten percent. This change follows India's recent actions against forced labo...

U.S. markets closed mixed as the Nasdaq declined on chip stock weakness driven by concerns over heavy AI spending, while the Dow rose and t...

The 10% temporary US tariff imposed on imports from India and other trading partners is set to expire at 9:31 am IST on July 24, unless the...

Trump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...

For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...

Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...

Donald Trump is likely planning new import duties on many nations by Friday. These levies aim to continue his tariff regime after current o...